Valuation : Feedback plc

Market Cap 30.01L 40.66L 34.96L 32.89L 56.01L 39Cr 56.3L 3.9Cr 1.51Cr 20Cr 1.53Cr 1.49Cr 63Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10.2L 13.81L 11.88L 11.17L 19.03L 13Cr 19.13L 1.32Cr 51.23L 6.69Cr 51.88L 50.74L 21Cr EV / Sales 2026 *
1.26x
EV / Sales 2027 * 4.83x
Free-Float
94.51%
Yield 2026 *
-
Yield 2027 * -
1 month+13.22%
3 months-10.46%
6 months-48.30%
Current year-28.83%
1 week 6.7
Extreme 6.7
7
1 month 6
Extreme 6
7
Current year 5.8
Extreme 5.8
15
1 year 5.8
Extreme 5.8
15
3 years 5.8
Extreme 5.8
152.92
5 years 5.8
Extreme 5.8
274.8
10 years 5.8
Extreme 5.8
1,040
Manager TitleAgeSince
Chief Executive Officer 38 09/04/2019
Director of Finance/CFO 54 10/11/2025
Compliance Officer 56 01/02/2001
Director TitleAgeSince
Director/Board Member 38 09/04/2019
Chairman 72 18/11/2019
Director/Board Member 55 03/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
23/12/25 Buy

Chief Executive Officer

60,904 0.1390%
23/12/25 Buy

Chief Financial Officer

60,549 0.1382%
10/07/25 Free

Public Communications Manager

2,19,073 0.5000%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-48.30%-92.17% 40.65L
-3.58%-5.18%-6.37%+20.18% 4.45TCr
+0.58%-5.46%-43.13%+131.78% 1.27TCr
+3.71%-0.82%-10.86%+76.98% 562.91Cr
+1.66%-1.84%+43.48% - 425.29Cr
-3.05%+0.92% - - 210.37Cr
-1.54%-2.26%+4.33%-37.15% 156.78Cr
+1.29%-1.39%-33.18% - 107.93Cr
+0.68%+1.87%+26.77%+146.90% 101.89Cr
+0.29%-8.02%+39.41%+47.47% 91Cr
Average -0.01%-0.72%-3.09%+42.00% 738.24Cr
Weighted average by Cap. -1.87%-1.47%-9.40%+47.33%

Financials

2026 *2027 *
Net sales 8L 10.97L 9L 9L 15.12L 10Cr 15.19L 1.05Cr 40.69L 5.32Cr 41.2L 40.3L 17Cr 8L 10.97L 9L 9L 15.12L 10Cr 15.19L 1.05Cr 40.69L 5.32Cr 41.2L 40.3L 17Cr
Net income - -
Net Debt -19.82L -26.84L -23.08L -21.71L -36.98L -25Cr -37.17L -2.57Cr -99.54L -13Cr -1.01Cr -98.6L -41Cr 9L 12.38L 10.65L 10.02L 17.06L 12Cr 17.15L 1.19Cr 45.92L 6Cr 46.5L 45.48L 19Cr
Logo Feedback plc
Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. The Company’s segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is its communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multidisciplinary team working and diagnostic-enhanced advice and guidance. CareLocker is its patient-facing platform that gives patients access and control over their diagnostic and other clinical data.
Employees
29
Date Price Change Volume
08/26/08 GBX 6.850 0.00% 0
07/26/07 GBX 6.850 0.00% 553
04/26/04 GBX 6.850 0.00% 230
03/26/03 GBX 6.850 0.00% 52
02/26/02 GBX 6.850 0.00% 3,427
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0685GBP
Average target price
0.6000GBP
Spread / Average Target
+775.91%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FDBK Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!